A detailed history of Hussman Strategic Advisors, Inc. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 10,500 shares of LNTH stock, worth $940,170. This represents 0.29% of its overall portfolio holdings.

Number of Shares
10,500
Holding current value
$940,170
% of portfolio
0.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$76.22 - $116.71 $800,310 - $1.23 Million
10,500 New
10,500 $939,000
Q3 2020

Nov 02, 2020

SELL
$11.98 - $16.34 $1.83 Million - $2.5 Million
-153,000 Closed
0 $0
Q3 2019

Oct 31, 2019

BUY
$21.01 - $28.94 $1.11 Million - $1.53 Million
53,000 Added 53.0%
153,000 $3.84 Million
Q2 2019

Jul 31, 2019

BUY
$23.33 - $28.3 $2.33 Million - $2.83 Million
100,000 New
100,000 $2.83 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.16B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.